Merck Receives CHMP Positive Opinion For New Fertility Treatment, ELONVA(R)
Merck & Co., Inc. announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of ELONVA® (corifollitropin alfa injection) as a treatment in controlled...



